ABSTRACT
PURPOSE: Radiation dose received by the neural stem cells of the hippocampus during whole-brain radiotherapy has been associated with neurocognitive decline. The key concern using hippocampal avoidance-prophylactic cranial irradiation (HA-PCI) in patients with small-cell lung cancer (SCLC) is the incidence of brain metastasis within the hippocampal avoidance zone. METHODS: This phase III trial enrolled 150 patients with SCLC (71.3% with limited disease) to standard prophylactic cranial irradiation (PCI; 25 Gy in 10 fractions) or HA-PCI. The primary objective was the delayed free recall (DFR) on the Free and Cued Selective Reminding Test (FCSRT) at 3 months; a decrease of 3 points or greater from baseline was considered a decline. Secondary end points included other FCSRT scores, quality of life (QoL), evaluation of the incidence and location of brain metastases, and overall survival (OS). Data were recorded at baseline, and 3, 6, 12, and 24 months after PCI. RESULTS: Participants' baseline characteristics were well balanced between the two groups. The median follow-up time for living patients was 40.4 months. Decline on DFR from baseline to 3 months was lower in the HA-PCI arm (5.8%) compared with the PCI arm (23.5%; odds ratio, 5; 95% CI, 1.57 to 15.86; P = .003). Analysis of all FCSRT scores showed a decline on the total recall (TR; 8.7% v 20.6%) at 3 months; DFR (11.1% v 33.3%), TR (20.3% v 38.9%), and total free recall (14.8% v 31.5%) at 6 months, and TR (14.2% v 47.6%) at 24 months. The incidence of brain metastases, OS, and QoL were not significantly different. CONCLUSION: Sparing the hippocampus during PCI better preserves cognitive function in patients with SCLC. No differences were observed with regard to brain failure, OS, and QoL compared with standard PCI.
Subject(s)
Brain Neoplasms/prevention & control , Cranial Irradiation , Hippocampus/drug effects , Lung Neoplasms/radiotherapy , Radiation Injuries/prevention & control , Small Cell Lung Carcinoma/radiotherapy , Adult , Aged , Aged, 80 and over , Brain Neoplasms/mortality , Brain Neoplasms/secondary , Cognition/radiation effects , Cranial Irradiation/adverse effects , Cranial Irradiation/mortality , Dose Fractionation, Radiation , Female , Hippocampus/physiopathology , Humans , Lung Neoplasms/mortality , Lung Neoplasms/pathology , Male , Mental Recall/radiation effects , Middle Aged , Organ Sparing Treatments , Quality of Life , Radiation Injuries/etiology , Radiation Injuries/physiopathology , Radiation Injuries/psychology , Small Cell Lung Carcinoma/mortality , Small Cell Lung Carcinoma/secondary , Spain , Time Factors , Treatment OutcomeABSTRACT
Introducción: la estimulación cortical directa (DCS) es una metodología corrientemente usada para localizar áreas del lenguaje en intervenciones quirúrgicas que incluyan resecciones.La estimulación magnética transcraneana repetitiva (rTMS) a demostrado también su capacidad para inducir alteraciones transitorias. Recientemente el desarrollo del Sistema de Navegación de TMS asegura precisa localización del sitio estimulado. El objetivo del trabajo es estudiar la confiabilidad de la estimulación magnética transcraneal repetitiva navegada (nrTMS) en la localización de los sitios del lenguaje. Métodos: Once pacientes seleccionados para mapeo del lenguaje por DCS fueron evaluados pre-cirugía con nrTMS. Los mapeos de lenguaje prequirúrgicos mediante nrTMS fueron comparados con DCS. Resultados: Un total de 25 nrTMS sitios del lenguaje y 38 DCS fueron localizados. La sensibilidad y la especificidad obtenida fue de 88.4 y 95.6, respectivamente. La distancia media fue evaluada en 4,5mm. Conclusiones: Los dispositivos de nrTMS permiten la identificación de las áreas corticales del lenguaje. Con un alto grado de concordancia con el mapeo TMS. La nrTMS se muestra como una herramienta de interés en la investigación y aplicación práctica en la función del lenguaje.
Introduction: direct cortical stimulation (DCS) is currently used to localise language areas in surgical resections. Repetitive transcranial magnetic stimulation (rTMS) has also shown its capacity to induce transient language alterations. Newly developed Navigated Brain Systems of TMS ensure precise topographical localisation of the stimulated site. The objective was to study the reliability of navigated repetitive transcranial magnetic stimulation (nrTMS) in language sites localisation.Methods: Eleven patients selected for DCS language mapping were presurgically evaluated with nrTMS. These presurgicalnrTMS language maps were then compared with DCS.Results: A total number of 25 nrTMS and 38 DCS language sites were localised. Sensitivity and specificity were calculated as 88.4 and 95.6 respectively. Mean distance was assessed as 4.5 millimetres. Conclusions: nrTMS devices allow identification of cortical language areas, with a high degree of concordance to TMS mapping. NrTMS shows up as an interesting tool for research and practical application in language function.
Subject(s)
Deep Brain Stimulation , Language Development Disorders , Malformations of Cortical DevelopmentABSTRACT
The application of the Boston Naming Test (BNT) is time-consuming and shortened versions need to be developed for screening purposes. The aims of this study were to develop four equivalent 15-item forms of a Spanish adaptation of the BNT, to test the equivalence of the new versions in a clinical sample, and to provide normative data. The normative sample consisted of 340 subjects. The clinical sample included 172 patients (76 Mild Cognitive Impairment and 96 Alzheimer's disease). An empirical procedure was used to develop the shortened versions. All new versions demonstrated satisfactory internal consistency. Pearson's coefficient analysis showed strong relationships among the four short-form versions as well as between each of them and the 60-item test. The inferential confidence interval method demonstrated the equivalence between the four shortened versions. Age and education affected the score of all short-form versions, but sex was found to be unrelated to the performance. Normative data were calculated for midpoint age groups. This paper proposes four 15-item equivalent versions that could be useful and time-saving tools for screening purposes.
Subject(s)
Alzheimer Disease/diagnosis , Cognitive Dysfunction/diagnosis , Neuropsychological Tests , Age Factors , Aged , Aged, 80 and over , Alzheimer Disease/psychology , Analysis of Variance , Cognitive Dysfunction/psychology , Female , Humans , Male , Mental Status Schedule , Middle Aged , Reference Values , Spain , Statistics as Topic , TranslatingABSTRACT
The abbreviated Barcelona Test (a-BT) is an instrument widely used in Spain and Latin American countries for general neuropsychological assessment. The purpose of the present study was to provide new norms for the a-BT as part of the Neuronorma project. The sample consisted of 346 healthy controls. Overlapping cell procedure and midpoint techniques were applied to develop the normative data. Age, education, and sex influences were studied. Results indicated that although age and education affected the score on this test, sex did not. Raw scores were transformed to age-adjusted scaled scores (SS(A)) based on percentile ranks. These SS(A) were also converted into age-education scaled scores using a linear regression model. Norms were presented on age-education scaled scores. Also, the a-BT cognitive profile was presented and should prove to be clinically useful for interpretation. These co-normed data will allow clinicians to compare scores from a-BT with all the tests included in the Neuronorma project.
